Name: Eupraxia Pharmaceuticals Inc. (EPRX) Balance Sheet
Creator: FinSpry

Eupraxia Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Eupraxia Pharmaceuticals Inc. (EPRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	33.10	19.34	18.26	16.39	0.12
Short-Term Investments	0.00	0.00	0.00	7.07	0.00
Cash & Short-Term Investments	33.10	19.34	18.26	23.45	0.12
Accounts Receivable	0.23	0.19	0.09	0.34	0.49
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.11	0.27	0.24	0.21	0.29
Total Current Assets	34.44	19.80	18.59	24.00	0.89
Non-Current Assets
Property, Plant & Equipment (Net)	0.42	0.46	0.53	0.46	0.25
Other Non-Current Assets	0.08	0.01	0.00	0.02	0.00
Total Non-Current Assets	0.51	0.46	0.53	0.49	0.32
Total Assets	50.24	20.27	19.12	24.49	1.14
Current Liabilities
Accounts Payable	0.00	5.04	3.97	2.11	7.33
Short-Term Debt	0.18	10.40	0.08	0.07	0.00
Current Portion of Long-Term Debt	0.00	10.40	0.08	0.08	0.00
Accrued Liabilities	3.01	3.03	2.42	1.07	2.38
Other Current Liabilities	4.29	5.02	0.02	0.00	5.44
Total Current Liabilities	4.46	19.37	3.06	1.78	17.69
Non-Current Liabilities
Long-Term Debt	0.00	0.00	8.80	7.27	0.20
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.30
Total Non-Current Liabilities	0.00	0.00	8.86	7.37	0.57
Total Liabilities	4.46	19.37	11.91	9.15	18.14
Stockholders' Equity
Common Stock	116.36	92.91	71.00	63.30	18.68
Retained Earnings	-131.00	-105.50	-77.28	-58.18	-40.18
Accumulated Other Comprehensive Income	-4.16	-2.71	-2.79	13.09	0.00
Additional Paid-in Capital	20.50	17.51	16.85	10.87	6.19
Minority Interest	-1.57	-1.32	-0.58	-0.65	-0.45
Shares Outstanding	35.64	27.28	21.59	14.24	0.00
Total Stockholders' Equity	33.40	2.22	7.79	15.99	-17.00
Total Liabilities & Equity	34.94	20.27	19.12	24.49	1.45